Bristol Net Income Per Share from 2010 to 2026

BMY Stock  USD 60.74  0.88  1.47%   
Bristol Myers Net Income Per Share yearly trend continues to be fairly stable with very little volatility. Net Income Per Share is likely to outpace its year average in 2026. During the period from 2010 to 2026, Bristol Myers Net Income Per Share regression line of annual values had r-squared of  0.01 and arithmetic mean of  1.44. View All Fundamentals
 
Net Income Per Share  
First Reported
2010-12-31
Previous Quarter
3.45565899
Current Value
3.63
Quarterly Volatility
2.37933882
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 B, Interest Expense of 1.6 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0278 or PTB Ratio of 7.0. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Build AI portfolio with Bristol Stock
Check out the analysis of Bristol Myers Correlation against competitors.
The evolution of Net Income Per Share for Bristol Myers Squibb provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Bristol Myers compares to historical norms and industry peers.

Latest Bristol Myers' Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Bristol Myers Squibb over the last few years. It is Bristol Myers' Net Income Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Very volatile
   Net Income Per Share   
       Timeline  

Bristol Net Income Per Share Regression Statistics

Arithmetic Mean1.44
Geometric Mean2.04
Coefficient Of Variation164.71
Mean Deviation1.66
Median2.02
Standard Deviation2.38
Sample Variance5.66
Range8.2931
R-Value0.07
Mean Square Error6.01
R-Squared0.01
Significance0.78
Slope0.03
Total Sum of Squares90.58

Bristol Net Income Per Share History

2026 3.63
2025 3.46
2024 -4.41
2023 3.88
2022 2.97
2021 3.15
2020 -3.98

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Net Income Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income Per Share 3.46  3.63 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.